HRP20070196T3 - Postupak za pročišćavanje il-18 vezivnog proteina - Google Patents

Postupak za pročišćavanje il-18 vezivnog proteina

Info

Publication number
HRP20070196T3
HRP20070196T3 HR20070196T HRP20070196T HRP20070196T3 HR P20070196 T3 HRP20070196 T3 HR P20070196T3 HR 20070196 T HR20070196 T HR 20070196T HR P20070196 T HRP20070196 T HR P20070196T HR P20070196 T3 HRP20070196 T3 HR P20070196T3
Authority
HR
Croatia
Prior art keywords
binding protein
purification
procedure
purified
production
Prior art date
Application number
HR20070196T
Other languages
English (en)
Croatian (hr)
Inventor
Rossi Mara
Ziegler Thierry
Valognes Laure
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Publication of HRP20070196T3 publication Critical patent/HRP20070196T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR20070196T 2003-11-05 2004-11-04 Postupak za pročišćavanje il-18 vezivnog proteina HRP20070196T3 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51744703P 2003-11-05 2003-11-05
EP03104092 2003-11-05
PCT/EP2004/052807 WO2005049649A1 (fr) 2003-11-05 2004-11-04 Procede de purification de la proteine de liaison il-18

Publications (1)

Publication Number Publication Date
HRP20070196T3 true HRP20070196T3 (hr) 2007-06-30

Family

ID=34924126

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070196T HRP20070196T3 (hr) 2003-11-05 2004-11-04 Postupak za pročišćavanje il-18 vezivnog proteina

Country Status (19)

Country Link
US (1) US7820800B2 (fr)
EP (1) EP1689777B1 (fr)
JP (1) JP4741504B2 (fr)
AT (1) ATE360647T1 (fr)
AU (1) AU2004291341B2 (fr)
CA (1) CA2544146C (fr)
CY (1) CY1106683T1 (fr)
DE (1) DE602004006157T2 (fr)
DK (1) DK1689777T3 (fr)
ES (1) ES2285543T3 (fr)
HR (1) HRP20070196T3 (fr)
IL (1) IL175431A (fr)
ME (1) ME01198B (fr)
NO (1) NO330538B1 (fr)
PL (1) PL1689777T3 (fr)
PT (1) PT1689777E (fr)
RS (1) RS50516B (fr)
SI (1) SI1689777T1 (fr)
WO (1) WO2005049649A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE399872T1 (de) 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
DK1622939T3 (da) * 2003-05-13 2012-04-10 Merck Serono Sa Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
ATE484591T1 (de) * 2003-10-21 2010-10-15 Merck Serono Sa Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
DE602005002829T2 (de) * 2004-03-01 2008-07-10 Ares Trading S.A. Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
AU2005259269B2 (en) 2004-06-29 2010-12-09 Ares Trading S.A. Process for the purification of IL-18 binding protein
US8129508B2 (en) 2005-04-11 2012-03-06 Medarex, Inc. Protein purification using HCIC and ion exchange chromatography
ES2385639T3 (es) 2005-06-03 2012-07-27 Ares Trading S.A. Producción de una proteína de unión a IL-18 recombinante
AU2006256763B2 (en) * 2005-06-10 2012-08-02 Ares Trading S.A. Process for the purification of IL-18 binding protein
CN101874042B9 (zh) 2007-09-26 2019-01-01 中外制药株式会社 利用cdr的氨基酸取代来改变抗体等电点的方法
AU2009204998B2 (en) 2008-01-18 2014-03-27 F. Hoffmann-La Roche Ag Purification of non-glycosylated proteins
EP2275443B1 (fr) 2008-04-11 2015-12-02 Chugai Seiyaku Kabushiki Kaisha Molécule de liaison à l antigène capable de se lier à deux molécules d antigène ou plus de manière répétée
TWI440469B (zh) 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
WO2011156369A2 (fr) * 2010-06-07 2011-12-15 Dr. Reddy's Laboratories Ltd. Purification de cytokines modifiées
TWI654204B (zh) 2010-11-30 2019-03-21 Chugai Seiyaku Kabushiki Kaisha 具有鈣依存性的抗原結合能力之抗體
CA2827923C (fr) 2011-02-25 2021-11-23 Chugai Seiyaku Kabushiki Kaisha Anticorps fc specifique de fcgriib
JP6147726B2 (ja) 2011-03-29 2017-06-14 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ タンパク質精製のためのバッファー系
TW201817744A (zh) 2011-09-30 2018-05-16 日商中外製藥股份有限公司 具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
US20150050269A1 (en) 2011-09-30 2015-02-19 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
CA3233142A1 (fr) 2011-11-30 2013-06-06 Chugai Seiyaku Kabushiki Kaisha Support contenant des medicaments dans une cellule pour former un complexe immunitaire
WO2013125667A1 (fr) 2012-02-24 2013-08-29 中外製薬株式会社 MOLÉCULE DE LIAISON D'ANTIGÈNE DESTINÉE À FAVORISER LA DISPARITION D'ANTIGÈNE VIA LE RÉCEPTEUR FcγRIIB
TWI636062B (zh) 2013-04-02 2018-09-21 中外製藥股份有限公司 Fc region variant
SI3116891T1 (sl) * 2014-03-10 2020-07-31 Richter Gedeon Nyrt. Čiščenje imunoglobulina z uporabo predčistilnih stopenj
CN107001411B (zh) * 2014-12-15 2021-07-23 默克专利股份公司 从粗溶液捕获靶分子
NZ730607A (en) 2014-12-19 2022-07-01 Chugai Pharmaceutical Co Ltd Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
SG10201710322VA (en) 2014-12-19 2018-02-27 Chugai Pharmaceutical Co Ltd Anti-c5 antibodies and methods of use
WO2016125495A1 (fr) 2015-02-05 2016-08-11 Chugai Seiyaku Kabushiki Kaisha Anticorps comprenant un domaine se liant à l'antigène dépendant de la concentration d'ions, variants de la région fc, anticorps se liant à l'il-8, et leurs utilisations
TWI873632B (zh) 2015-02-27 2025-02-21 日商中外製藥股份有限公司 Il-6受體抗體用於製備醫藥組成物的用途
WO2017110981A1 (fr) 2015-12-25 2017-06-29 Chugai Seiyaku Kabushiki Kaisha Anticorps anti-myostatine et procédés d'utilisation
BR112019001902A2 (pt) 2016-08-05 2019-07-09 Chugai Seiyaku Kabushiki Kaisha composição para profilaxia ou tratamento de doenças relacionadas à il-8
JP7191833B2 (ja) 2017-01-30 2022-12-19 中外製薬株式会社 抗スクレロスチン抗体およびその使用
US11851486B2 (en) 2017-05-02 2023-12-26 National Center Of Neurology And Psychiatry Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
CA2340579A1 (fr) * 1998-09-01 2000-03-09 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Proteine de liaison de l'interleukine 18
JP4216950B2 (ja) * 1998-09-01 2009-01-28 株式会社林原生物化学研究所 インターロイキン−１８結合蛋白質
US20020052475A1 (en) * 2000-07-20 2002-05-02 Schering Ag High affinity soluble interleukin-18 receptor
DK1392830T3 (da) * 2001-03-08 2006-05-08 Ares Trading Sa Interleukin-18 mutanter, deres fremstilling og anvendelse
CA2451955C (fr) * 2001-06-26 2015-09-29 Abgenix, Inc. Anticorps opgl
EP1495055B1 (fr) * 2002-04-18 2013-08-14 Genencor International, Inc. Production d'anticorps fonctionnels dans des champignons filamenteux
ATE399872T1 (de) 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
DK1622939T3 (da) 2003-05-13 2012-04-10 Merck Serono Sa Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
ATE484591T1 (de) 2003-10-21 2010-10-15 Merck Serono Sa Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression
DE602005002829T2 (de) 2004-03-01 2008-07-10 Ares Trading S.A. Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
AU2005259269B2 (en) 2004-06-29 2010-12-09 Ares Trading S.A. Process for the purification of IL-18 binding protein
ES2385639T3 (es) * 2005-06-03 2012-07-27 Ares Trading S.A. Producción de una proteína de unión a IL-18 recombinante
AU2006256763B2 (en) 2005-06-10 2012-08-02 Ares Trading S.A. Process for the purification of IL-18 binding protein

Also Published As

Publication number Publication date
EP1689777A1 (fr) 2006-08-16
AU2004291341A1 (en) 2005-06-02
US20070037734A1 (en) 2007-02-15
DK1689777T3 (da) 2007-06-11
IL175431A (en) 2011-02-28
CA2544146C (fr) 2012-10-02
ATE360647T1 (de) 2007-05-15
PT1689777E (pt) 2007-05-31
DE602004006157D1 (de) 2007-06-06
NO330538B1 (no) 2011-05-09
ES2285543T3 (es) 2007-11-16
CY1106683T1 (el) 2012-05-23
US7820800B2 (en) 2010-10-26
IL175431A0 (en) 2006-09-05
PL1689777T3 (pl) 2007-09-28
ME01198B (fr) 2013-03-20
AU2004291341B2 (en) 2010-08-05
RS50516B (sr) 2010-05-07
SI1689777T1 (sl) 2007-08-31
CA2544146A1 (fr) 2005-06-02
NO20062545L (no) 2006-08-03
WO2005049649A1 (fr) 2005-06-02
JP4741504B2 (ja) 2011-08-03
JP2007533651A (ja) 2007-11-22
EP1689777B1 (fr) 2007-04-25
DE602004006157T2 (de) 2008-01-03

Similar Documents

Publication Publication Date Title
NO20062545L (no) Fremgangsmate for rensing av IL-18-bindende protein
PT1473036E (pt) Solvato de hemitartarato de zolpidem
TW200509892A (en) Novel aminobenzophenone compounds
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
CY1112312T1 (el) Διεργασια για τον καθαρισμο της πρωτεϊνης δεσμευσης της ιl-18
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
SE0301650D0 (sv) Novel compounds
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
DE602004018155D1 (de) Einen grössenausschlussschritt verwendendes verbessertes bisulfit-verfahren
MXPA03008946A (es) Metodos para sintetizar compuestos que contienen fenol.
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
UA87117C2 (ru) Применение пептидных соединений для лечения центральной невропатической боли
EP1436279B8 (fr) Composes chimiques
NO20053829D0 (no) Fremgangsmate og intermediater for fremstilling av olanzapin.
MXPA04004757A (es) Uso de una ascomicina para el tratamiento de blefaritis.
TW200504218A (en) Methods for preventing gluconoylation of proteins
DK1687301T3 (da) Thiaepothilone til behandling af kræftsygdomme
ATE295746T1 (de) Radioaktiv beschichtete stents
CY1116631T1 (el) Καθαρισμος πρωτεϊνων με τεχνικη μη-συγγενειας
FI20031420A7 (fi) Menetelmä uusien 7-substituoitu-9-(substituoitu amino)-6-demetyyli-6-deoksitetrasykliinien valmistamiseksi
ITTO20010303A0 (it) Impianto di legatura per la realizzazione di libri.
UY34598A (es) Antranilamidas insecticidas